INMB vs VRTX: Which Stock is Better?
Side-by-side comparison of Inmune Bio Inc and Vertex Pharmaceuticals Inc in 2026
INMB
Inmune Bio Inc
$1.29
VRTX
Vertex Pharmaceuticals Inc
$439.18
Key Metrics Comparison
| Metric | INMB | VRTX | Winner |
|---|---|---|---|
| Market Cap | $33.50M | $113.01B | VRTX |
| P/E Ratio | N/A | 28.98 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 2.6% | 0.1% | INMB |
| Gross Margin | 100.0% | 53.7% | INMB |
Analyze INMB
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INMB or VRTX a better investment?
Comparing INMB and VRTX: Inmune Bio Inc has a market cap of $33.50M while Vertex Pharmaceuticals Inc has $113.01B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INMB and VRTX?
INMB (Inmune Bio Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INMB or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INMB or VRTX?
INMB has higher revenue growth at 2.6% vs 0.1% for VRTX.
Which company is more profitable: INMB or VRTX?
Inmune Bio Inc (INMB) has higher gross margins at 100.0% compared to 53.7% for VRTX.
Which is the larger company: INMB or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.01B compared to $33.50M for INMB.
Should I buy INMB or VRTX in 2026?
Both INMB and VRTX have investment merit. INMB trades at $1.29 while VRTX trades at $439.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INMB and VRTX stock?
Key differences: Market Cap ($33.50M vs $113.01B), P/E Ratio (N/A vs 29.0x), Revenue Growth (2.6% vs 0.1%), Gross Margin (100.0% vs 53.7%).